Home › Research › How common it is
Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset.
Ron Brookmeyer, Steven G. Gray, Claudia H. Kawas. American Journal of Public Health, 1998-09-01
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
in 1997, the prevalence of Alzheimer's disease in the United States was 2.32 million (range: 1.09 to 4.58 million); of these individuals, 68% were female. It is projected that the prevalence will nearly quadruple in the next 50 years, by which time approximately 1 in 45 Americans will be afflicted with the disease. Currently, the annual number of new incident cases in 360,000. If interventions could delay onset of the disease by 2 years, after 50 years there would be nearly 2 million fewer cases than projected; if onset could be delayed by 1 year, there would be nearly 800,000 fewer prevalent cases. As the US population ages, Alzheimer's disease will become an enormous public health problem. interventions that could delay disease onset even modestly would have a major public health impact.
What this study adds
Evidence grade: Low
This projection suggests that interventions able to delay the onset of Alzheimer's disease by even 1 or 2 years could substantially reduce the number of people living with the disease over the coming decades. It does not test any treatment, but shows the potential public health value of prevention or delay strategies.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Brookmeyer, R., Gray, S. G., & Kawas, C. H. (1998). Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. American Journal of Public Health. https://doi.org/10.2105/ajph.88.9.1337
Vancouver
Brookmeyer R, Gray SG, Kawas CH. Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. American Journal of Public Health. 1998. doi:10.2105/ajph.88.9.1337. PMID: 9736873.
BibTeX
@article{brookmeyer1998-9736873,
author = {Brookmeyer, Ron and Gray, Steven G. and Kawas, Claudia H.},
title = {{Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset}},
journal = {American Journal of Public Health},
year = {1998},
doi = {10.2105/ajph.88.9.1337},
pmid = {9736873},
url = {https://doi.org/10.2105/ajph.88.9.1337}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- in 1997, the prevalence of Alzheimer's disease in the United States was 2.32 million (range: 1.09 to 4.58 million); of these individuals, 68% were female.
- It is projected that the prevalence will nearly quadruple in the next 50 years, by which time approximately 1 in 45 Americans will be afflicted with the disease.
- Currently, the annual number of new incident cases in 360,000.
- If interventions could delay onset of the disease by 2 years, after 50 years there would be nearly 2 million fewer cases than projected; if onset could be delayed by 1 year, there would be nearly 800,000 fewer prevalent cases.
- As the US population ages, Alzheimer's disease will become an enormous public health problem. interventions that could delay disease onset even modestly would have a major public health impact.
Why it matters
This projection suggests that interventions able to delay the onset of Alzheimer's disease by even 1 or 2 years could substantially reduce the number of people living with the disease over the coming decades. It does not test any treatment, but shows the potential public health value of prevention or delay strategies.
New to this subject? Start with our plain-English guide: Alzheimer's in numbers →
Study details
- Evidence strengthLow
How this study scored 57/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (American Journal of Public Health) |
| Journal's citation record | 3 / 4 | American Journal of Public Health: journal h-index 422 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 1 / 5 | 1998 — older than 20 years, still counted |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 7 / 7 | Cited 1,803 times (OpenAlex, 2026-10-10) |
| Citations per year | 5 / 5 | 60.1 citations a year over 30 year(s) since 1998 |
| Impact for its field and year | 5 / 6 | Cited 24.2× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 5 / 6 | Cited by 121 other studies in this library |
| Still being cited | 3 / 4 | Cited 90 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 3 / 4 | Last-listed author Claudia H. Kawas: h-index 85 (OpenAlex, whole career) |
| Institution's track record | 2 / 3 | Johns Hopkins University: institution h-index 2,306 (OpenAlex) |
| Multicenter collaboration | 1 / 3 | OpenAlex lists 3 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 9736873) |
| Free to read | 2 / 2 | Free to read |
| Total | 57 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.2105/ajph.88.9.1337
- PubMed: 9736873
- Original source →
- Free full text: American Journal of Public Health →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Later studies that cite this one
121 studies in the alzhub library list this one in their references. Showing the 8 highest-scoring.
Related studies in How common it is from nearby years
Also in How common it is
80 studies in the library are filed under How common it is with no topic tag they share with another; these are this study's neighbours in a fixed tour of them. The How common it is hub.